论文部分内容阅读
福尼尔集团（Ｆｏｕｒｎｉｅｒ）的雌二醇透皮贴剂有望于１９９９年在美国上市。虽然目前市场上的雌二醇贴剂已有罗纳普朗克和先灵等公司的销售产品，但Ｅｓｃｌｉｍ因具有剂量选择范围广、粘着性好和易耐受等优点，足以立足于竞争激烈的雌激素透皮制剂市场。比如它的最低...
Fournier’s estradiol transdermal patches are expected to be available in the United States in 1999. Although estradiol patches currently on the market have been marketed by companies such as Rhone-Poulenc and Schering, Esclim is well-positioned to compete on the basis of its wide range of dosage options, good adhesion and ease of use Estrogen transdermal agent market. For example, it’s the lowest ...